Bios Life Clinical Trials

Clinically Tested, Peer Accepted:

Studied at North America's Leading Scientific and Medical Research Centers.

Unicity products have been extensively reviewed 

in peer reviewed clinical studies conducted 

at several of the most prestigious hospitals and 

universities in the US and globally. 

Unicity continues to dedicate a large portion of the company budget 

to continued science and research.

Unicity’s flagship product, 

BALANCE (Bios Life SLIM) meets 

the NCEP(National. Cholesterol Education Program) guidelines

for first-line treatment of primary dyslipidemia. 

It has also been studied as an adjunct to statins.

Eleven Unicity Products 

including Bios Life are listed in the PDR (Physician's Desk Reference).

Unicity products are manufactured in FDA-approved facilities 

under stringent good manufacturing practices (GMP), 

as defined by government regulatory procedures. 

Where applicable, patented and standardized ingredients 

are used in the formulating and production processes.

Bios Life UNICITY BALANCE - Clinical Studies:

Cleveland Clinic Trial by Dr. Dennis Sprecher 
Published in Sprecher DL, Pearce GL (2002)
Fiber-multivitamin combination therapy: a beneficial influence on lowdensity lipoprotein and homocysteine Metabolism 51, 1166-70.
Cleveland_Clinic_Trial_Dennis_Sprecher.pdf

Diabetes in Control Study #1 by Steven Freed and David Joffe 
Published in Freed S, Joffe D (2000)
The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications
from Diabetes Diabetes in Control 12-8.
Diabetes-in-Control-Study_Steven_Freed_David_Joffe.pdf

Diabetes in Control Study #2 by Steven Freed and David Joffe 
Published in Freed S, Joffe D (2004)
The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications
from Diabetes II Diabetes in Control 212, 17,
and Verdegem P, Freed S, Joffe D (2005)
The clinical impact of fiber supplementation for the reduction of postprandial blood glucose and reduction of complications
from type-2 diabetes Diabetes 54, A425.
Diabetes_in_Control_Study_2.pdf

The Clinical Impact of Fiber Supplementation on Cardio-Vascular Risk Parameters in type-2 Diabetes.
Presented by Verdegem P, Freed S, Joffe D. in 6th International Conference on Atherosclerosis,
Thrombosis and Vascular Biology. 2005. Washinton, DC, USA. The American Heart Association sent out a press release on the study results.
Abstract - Poster-ADA-2005.pdf - (AHA) American-Heart-Association-Press-Release.pdf

The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Type-2 Diabetes.
Presented by Verdegem P, Freed S, Joffe D. in 65th Scientific Session American Diabetes Association. 2005. San Diego, CA, USA.
Poster-ADA-2005.pdf

Philippines Trial by Dr. Yumul 
Presented by Balajadia E, Valerio A, Yumul N.
Beneficial effects of Bios Life 2 (Dietary Fiber Supplement) in patients with dyslipidemia.
in 34th Annual Convention of the Philippine College of Physicians. 2004.
Phillippines Trial Dr. Yumul.pdf

Utah Trial by Dr. Peter J.E. Verdegem 
As published by Verdegem P (2007)
Viscous soluble fiber combined with phytosterols and policosanol reduces LDL-c and increases HDL-c in hypercholesterolemia Current Topics
in Neutraceutical Research.
Utah Trial.pdf

Utah Trial #2 by Dr. Peter J.E. Verdegem 
As presented by Verdegem P, Duenas V, Duenas J, Burke E.
LDL- and HLD-cholesterol optimization using phytonutrient combination therapy: first line intervention and adjunct therapy to statins
in 1st Asian Preventive Cardiology & Cardiac Rehabilitation Conference. 2006. Hong Kong.
Presented at the 7th International Congress on Coronary Artery Disease, 2007, Venice, Italy.
Utah Trial 2.pdf

Pacific Rim Trial by Dr. Vincent Duenas 
Published in Duenas V, Duenas J, Burke E, Verdegem P (2006)
A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia Arterioscler Thromb Vasc Biol 26, e53-e107.
Pacific Rim Trial Vincent Duenas.pdf

A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia.
Presented by Duenas V, Duenas J, Burke E, Verdegem P.
in 7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2006. Denver.
Poster-ATVB-2005-1.pdf - Poster for total users group.pdf - Poster Statin User Group.pdf

Texas Trial by Dr. Isabel Martinez 
Presented by Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. in 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago.